EUVIMEDEUVIMED entdecken
Open Access

Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation

Chun-Ka Wong iD, Yuen-Kwun Wong iD, Yap-Hang Chan iD, Minqing Lin iD, Jojo Siu-Han Hai iD, Kai-Hang Yiu iD, Gregory Yh Lip iD, Kui-Kai Lau iD, Hung-Fat Tse iD

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.038668 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Chun-Ka Wong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, School of Clinical Medicine Li Ka Shing Faculty of Medicine, The University of Hong Kong Hong Kong SAR China. Hauptthemen laut MEDLINE: Atrial Fibrillation, Anticoagulants, Gastrointestinal Hemorrhage, Intracranial Hemorrhages. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Non–vitamin K oral anticoagulants prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation. However, potential drug interactions with concomitant medications may compromise their efficacy and escalate the risk of adverse effects. Methods and Results We conducted a territory‐wide retrospective cohort study in Hong Kong, focusing on nonvalvular atrial fibrillation prescribed non–vitamin K oral anticoagulants. The objective was to investigate the associated risk of gastrointestinal bleeding, intracranial hemorrhage, hospitalization for major bleeding, and all‐cause mortality in relation to various concomitant medications. Our analysis included 22 568 patients with nonvalvular atrial fibrillation (aged 75.7 ± 10.8 years; 51.2% men) taking non–vitamin K oral anticoagulants from January 1, 2017, to December 31, 2020, totaling 40 317 patient‐years. It was found that amiodarone (hazard ratio [HR], 1.53), digoxin (HR, 1.30), diltiazem (HR, 1.18), clarithromycin (HR, 4.98), and fluconazole (HR, 2.38) were associated with increased gastrointestinal bleeding, whereas amiodarone (HR, 2.20) and digoxin (HR, 1.61) were associated with increased intracranial hemorrhage. Furthermore, amiodarone (HR, 1.64), digoxin (HR, 1.35), clarithromycin (HR, 4.18), and fluconazole (HR, 2.40) were associated with increased hospitalization for major bleeding. Additionally, amiodarone (HR, 2.65), digoxin (HR, 1.85), diltiazem (HR, 1.44), verapamil (HR, 1.80), antidepressants (HR, 1.31), and fluconazole (HR, 3.27) were associated with increased all‐cause mortality. Conversely, dronedarone (HR, 0.56) and atorvastatin (HR, 0.86) were associated with a significant reduction in all‐cause mortality.

Conclusions

For patients with nonvalvular atrial fibrillation taking non–vitamin K oral anticoagulants, several concurrent medications were associated with increased risks of intracranial hemorrhage, major bleeding hospitalizations, and overall mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAnticoagulantsGastrointestinal HemorrhageIntracranial HemorrhagesStrokeHemorrhageHumansMaleAgedFemaleRetrospective StudiesHong KongDrug InteractionsAged, 80 and overAdministration, OralRisk FactorsRisk Assessment

Stichwörter der Autor:innen

bleedingdrug interactionmortalitynonvalvular atrial fibrillationnon–vitamin K oral anticoagulant

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Medicine, School of Clinical Medicine Li Ka Shing Faculty of Medicine, The University of Hong Kong Hong Kong SAR China.
  • Cardiac and Vascular Center The University of Hong Kong-Shenzhen Hospital Shenzhen China.
  • Liverpool Centre for Cardiovascular Science University of Liverpool and Liverpool Heart and Chest Hospital Liverpool UK.
  • Department of Clinical Medicine Aalborg University Aalborg Denmark.
  • Hong Kong-Guangdong Stem Cell and Regenerative Medicine Research Centre The University of Hong Kong and Guangzhou Institutes of Biomedicine and Health Hong Kong SAR China.
  • Centre for Translational Stem Cell Biology Hong Kong SAR China.

ORCID-Profile: Chun-Ka Wong, Yuen-Kwun Wong, Yap-Hang Chan, Minqing Lin, Jojo Siu-Han Hai, Kai-Hang Yiu, Gregory Yh Lip, Kui-Kai Lau, Hung-Fat Tse

Zitieren

APA

Wong, C. K., Wong, Y. K., Chan, Y. H., Lin, M., Hai, J. S., Yiu, K. H., Lip, G. Y., Lau, K. K., & Tse, H. F. (2025). Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.038668

Vancouver

Wong CK, Wong YK, Chan YH, Lin M, Hai JS, Yiu KH, et al. Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.038668

BibTeX
@article{Wong2025,
  author = {Wong, Chun-Ka and Wong, Yuen-Kwun and Chan, Yap-Hang and Lin, Minqing and Hai, Jojo Siu-Han and Yiu, Kai-Hang and Lip, Gregory Yh and Lau, Kui-Kai and Tse, Hung-Fat},
  title = {Concomitant Drug Interactions With Non–Vitamin K Oral Anticoagulants Are Associated With Bleeding and Mortality Risk in Patients With Nonvalvular Atrial Fibrillation},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.038668}
}
Kostenlos starten →